Skin nerve &agr;-synuclein deposits: A biomarker for idiopathic Parkinson disease
暂无分享,去创建一个
Agostino Baruzzi | Sabina Capellari | A. Baruzzi | P. Martinelli | P. Avoni | R. Liguori | S. Capellari | C. Scaglione | M. P. Giannoccaro | Rocco Liguori | Vincenzo Donadio | Paolo Martinelli | V. Leta | Patrizia Avoni | Cesa Scaglione | Alex Incensi | Valentina Leta | Maria Pia Giannoccaro | A. Incensi | V. Donadio
[1] R. Djaldetti,et al. Skin biopsy for assessment of autonomic denervation in Parkinson’s disease , 2006, Journal of Neural Transmission.
[2] M. Feany,et al. New genetic insights into Parkinson's disease. , 2004, The New England journal of medicine.
[3] E. Masliah,et al. α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.
[4] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[5] S. Braune. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes , 2001, Clinical Autonomic Research.
[6] D. Calne. Progress in Parkinson's disease. , 1984, The New England journal of medicine.
[7] T. Iwatsubo,et al. Lewy Body Pathology Involves Cutaneous Nerves , 2008, Journal of neuropathology and experimental neurology.
[8] O. Levy,et al. The neuropathology of genetic Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[9] L. Santoro,et al. Neuropathy in idiopathic Parkinson disease: An Iatrogenic problem? , 2011, Annals of neurology.
[10] P. Cortelli,et al. Peripheral Autonomic Neuropathy: Diagnostic Contribution of Skin Biopsy , 2012, Journal of neuropathology and experimental neurology.
[11] A. Probst,et al. α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects , 2006, Neuropathology and applied neurobiology.
[12] P. Barone,et al. Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study , 2013, Movement disorders : official journal of the Movement Disorder Society.
[13] Bernardo Lanzillo,et al. Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation. , 2008, Brain : a journal of neurology.
[14] S. Wiebe,et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease , 2010, Annals of neurology.
[15] Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[16] H. Benamer,et al. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.
[17] L. Hakamies,et al. [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.
[18] T. Kanda,et al. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson’s disease and multiple system atrophy , 2009, Acta Neuropathologica.
[19] Maria Nolano,et al. Skin sympathetic adrenergic innervation: An immunofluorescence confocal study , 2006, Annals of neurology.
[20] Tapan P. Patel,et al. Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.
[21] A. Schapira. Recent developments in biomarkers in Parkinson disease , 2013, Current opinion in neurology.
[22] A. Probst,et al. New insights into the pathology of Parkinson’s disease: does the peripheral autonomic system become central? , 2008, European journal of neurology.
[23] P. Cortelli,et al. Skin sympathetic fiber &agr;-synuclein deposits: A potential biomarker for pure autonomic failure , 2013, Neurology.
[24] Yasuo Miki,et al. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease , 2010, Neuroscience Letters.
[25] C. Tanner,et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.
[26] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[27] R. Freeman,et al. Quantification of sudomotor innervation: A comparison of three methods , 2010, Muscle & nerve.
[28] Shalini Jha,et al. The diagnosis of Parkinson's disease. , 2003, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.
[29] E. Masliah,et al. alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.
[30] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[31] H. Shill,et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders , 2010, Acta Neuropathologica.
[32] Claire Henchcliffe,et al. Biomarkers in Parkinson's disease: an update. , 2012, Current opinion in neurology.
[33] D. Goldstein,et al. Sympathetic cardioneuropathy in dysautonomias. , 1997, Advances in pharmacology.
[34] L. Wilkins. Skin sympathetic fiber α-synuclein deposits: A potential biomarker for pure autonomic failure , 2014, Neurology.